Dyne Therapeutics Financial Overview
Dyne Therapeutics's market cap is currently $3.30B. The company's EPS TTM is $-0.76; its P/E ratio is -5.58; Dyne Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.
